Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase3, Open-Label, Clinical Trial of Zinc Acetate for Treatment of Wilson's Disease in Japan.

NCT00212355 is registered in ClinicalTrials.gov with Nobelpharma as lead sponsor.

NCT NCT00212355
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00212355 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase3, Open-Label, Clinical Trial of Zinc Acetate for Treatment of Wilson's Disease in Japan.
Lead sponsor
Nobelpharma
Phase
Phase 3
Overall status
Completed
Start date
March 31, 2005
Completion date
January 31, 2009
Enrollment
37 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

wilson's disease